The National Office of Animal Health has issued a statement criticising the All Party Parliamentary Group on Antibiotics report: "Non-human uses of antibiotics: time to restrict their use?”, saying it fails to recognise the steps that have already been taken by vets and farmers to prevent disease and minimise antibiotic use on farms where possible.
NOAH chief executive Dawn Howard said: "NOAH fully supports the need for responsible prescribing, by both the veterinary and medical professions.
"On the veterinary side, NOAH has been very actively involved with responsible use initiatives, such as the RUMA Alliance, which publishes guidelines supporting responsible use and has produced an action plan on livestock antibiotic resistance to implement Government strategy.“
NOAH highlights two particular aspects of the report. Firstly that it is critical of the treatment of groups of animals through medicated feed and water.
Dawn said: "There are many animal-friendly reasons why medicines can be prescribed in this way by a veterinary surgeon.
"For groups of animals, fish or birds there is less stress than injection or individual oral dosing. Where treatment is needed, the vet supplies a prescription for treatment through medicated feed or through the water, depending on the product being used. The whole process is highly regulated through European and national legislation."
The report also suggests certain classes of antibiotics should be reserved for humans. NOAH says it believes that veterinary surgeons need to retain the full range of currently licensed antibiotics in order to be able to treat the range of conditions that affect animals, and if they are restricted, animal welfare will undoubtedly suffer.
NOAH adds that removal of some classes from the veterinary sector would place undue selective pressure on the remaining classes which could increase resistance to those classes – having the opposite effect to what the committee probably intends.
Dawn said: “NOAH is disappointed not to have been consulted in advance of the publication of the report. We believe that responsible use of veterinary antibiotics is the best way to help preserve these precious medicines for us all, without compromising the health and welfare of our animals.”
The course, which is led by Mental Health First Aid England, comprises of two day-long sessions, the first of which will take place on Tuesday 9th January 2024 from 9am – 5pm and the second on Thursday 11th January.
The course costs £40 per person, and is open to all those working in the veterinary professions.
Advancement of the Professions and Mind Matters Director, Angharad Belcher, said: “This day long training session will help people to gain an understanding of what mental health is and how to challenge stigma, to gain the knowledge and confidence to advocate or mental health awareness, provide them with the ability to spot the signs of mental ill health and the skills to support positive wellbeing, as well as give people the confidence to support someone who is in distress or may be experiencing a mental health issue.
“While these sessions are open to all working in the veterinary professions, we are particularly encouraging vets working in rural areas or in ambulatory work to get involved.
"All veterinary work has its challenges, but we know from MMI funded research conducted by Scotland’s Rural College that rural and ambulatory veterinary work comes with its own set of challenges which is often compounded by working alone or having relatively limited contact with colleagues.
"Those working in rural areas often play integral roles within their local communities and it is therefore important to provide people with the skills to not only look after their own mental health, but with the opportunities to learn how to best support their friends and colleagues too.”
https://vetmindmatters.org/training
Dechra Veterinary Products has added a new webinar: 'Otitis Externa - Recent advances in the treatment of ears' to The Dechra Academy, the online training suite from Dechra Veterinary Products.
Presented by Sue Paterson, MA VetMB DVD DipECVD MRCVS RCVS & European Specialist in Veterinary Dermatology, the webinar accounts for 1.5 hours CPD and covers such topics as ear anatomy, cytology and the creation of treatment plans.
Carol Morgan, Dechra Brand Manager said: "We are dedicated to providing educational resources to support the veterinary profession. The otitis webinar is the latest addition to our range of high quality key-opinion-leader-led CPD on The Dechra Academy."
The webinar is now available to view on demand at www.dechra.co.uk/academy.
In June the College held a six-week consultation with the profession, asking for opinions on its proposal for an outcomes-based approach to CPD which would concentrate less on hours logged and more on interactive, reflective learning and measuring the impact that CPD has on the individual’s practice and patient health outcomes.
The proposed model for CPD had four key components: planning, doing, recording and reflecting. While an overall majority of the 3,357 people who responded to the College’s consultation agreed with the proposed changes to the CPD requirement, certain elements received less support than others. The lowest amount of support was received for the ‘reflection’ component with 35% of respondents disagreeing with it.
The RCVS Education Committee therefore decided that a pilot of a new outcomes-based approach should be held during 2017 with a group of volunteers, before making a recommendation to Council.
Professor Stephen May, who chaired the Working Group that developed the CPD proposals, said: "Because of the concern voiced by members of the profession responding to the consultation we decided that, at this stage, it would not be appropriate for the RCVS to move straight into this new way of doing CPD but that it would be more appropriate to hold a pilot. The idea is that we will explore some of the concerns around reflection and around the extra time and paperwork that people felt that a more reflective approach may lead to.
"We have taken all these comments into account and are now seeking to work with individual volunteers on this pilot. It is important to note that we are not only looking for volunteers who agree with what we are doing but also those who are apprehensive about it or even some who see it as something they do not support. We want to explore the full range of views and how we can move forward in changing our approach to CPD."
The pilot is expected to be launched in February next year and the College is now looking for volunteers who both support the proposals and have a ‘healthy scepticism’ about them. Volunteers will receive help and support throughout the trial and will also be invited to attend an introductory CPD meeting at the RCVS offices in February.
If you are interested in volunteering, contact Jenny Soreskog-Turp, RCVS CPD Officer, on cpd@rcvs.org.uk.
Further information, including the CPD Policy Working Party’s response to the consultation and the full interview with Stephen May, is available at www.rcvs.org.uk/CPDpilot.
Direct Line pet insurance had released the results of a survey in which 70% of dog owners claimed that not only did they get far more enjoyment buying gifts for their pets than their friends and family, but they also feel their pet understands when they're given a gift on a special occasion.
However, 17% of the 1,132 dog owners questioned revealed that their dogs always enjoy playing with the wrapping more than the gift, and 31% admitted that their pet sometimes chooses to play with the wrapping first.
Almost half (47%) are planning to make a special Christmas meal for their dogs. 63% are planning extra special treats over the festive period and 54% plan special family walks with their dog over Christmas.
According to the survey, 72% of Britain's dogs can expect a delivery from Santa left under the tree for them to spend the holidays enjoying.
Half of Britain's dogs will have an average of £15 (pounds sterling) spent on them this year with a lucky 3% having gifts worth more than £100 awaiting them.
If you're thinking it's worth doing a special display of Christmas gifts in the practice waiting room, you should know that the survey found toys were the most popular present, but pampering with warm winter coats and snuggly new beds were also high on the list of most desired presents.
K9 Magazine editor Ryan O'Meara said: "One of the great joys of giving a pet a Christmas gift is the absolute certainty that they will adore it. If the essence of gift giving is found in watching the reaction as the receiver's eyes light up and observing the sheer joy on their face, this is never more apparent than watching a dog open a £3.99 (pounds sterling) festive stocking filled with treats and toys. Dogs are the ultimate Christmas party animal. Happy to be the centre of attention, delighted to receive any gift - regardless of cost - and it is little wonder owners enjoy seeing their reactions on Christmas morning."
Ceva Animal Health has highlighted a new study which revealed that the use of the opioid buprenorphine, the active ingredient in Vetergesic, before equine elective general anaesthesia and surgery resulted in better post-operative analgesia than butorphanol, without causing further physiological disruption than is normally expected of general anaesthesia in horses.
The prospective, randomised and blinded multicentre study, conducted by Dr Polly Taylor VetMB MA PhD DVA DipECVAA MRCA MRCVS, an RCVS Specialist in Veterinary Anaesthesia, compared the degree of post-operative pain and physiological variables in horses following premedication with either buprenorphine or butorphanol in a general clinical setting. The study included 89 healthy adult horses from six UK equine veterinary clinics admitted for routine elective surgical procedures.
Ceva says that butorphanol is often used in equine procedures due to familiarity and its value for enhancing alpha2-induced sedation, but that it is probably the least effective opioid as an analgesic. There is also a common perception that butorphanol has less impact on locomotor stimulation and depression of intestinal motility than other opioids. This is likely to have contributed to the almost exclusive use of NSAIDs to manage pain in the post-operative period.
To view the full study, visit http://onlinelibrary.wiley.com/doi/10.1111/evj.12442/abstract. For details on Ceva's analgesic product range, email analgesics-group@ceva.com or call 01494 781510.
Underlying the plan are three 'Brexit Principles', devised by the College and formally adopted by RCVS Council, which will guide the College’s relationship with the Government during the forthcoming Brexit negotiations.
The College says each Principle is supported by a number of specific policies that the College will lobby for in the coming months, all designed to positively engage with the post-referendum reality and with government policy.
The Principles are:
RCVS Chief Executive Nick Stace said: "It is crucially important for the College and the profession as a whole to think boldly about the post-Brexit future; we cannot expect government to give us all of the answers, instead we must work to find solutions ourselves so as to shape the future of the profession from within."
The College has also asked the Institute for Employment Studies (IES) to undertake research into the attitudes and intentions of all EU-graduated veterinary surgeons and veterinary nurses currently working in the UK. They will all have receive a personalised email from IES with a link to this online survey, and their answers will help inform the College’s approach to Brexit. This research will help the College to understand better the impact that Brexit may already be having, how it can support EU veterinary professionals working in the UK, and build an evidence base regarding the potential impact that Brexit may have on the veterinary workforce.
For more information on the College’s Brexit activities, visit: www.rcvs.org.uk/brexit
The company, which until now has only offered loans to practice clients for veterinary treatment, is now offering practice staff loans of £1,000-£25,000 for periods ranging from 1-5 years at an APR from 7.9%, with joint applications acceptable.
Stewart Halperin, BVMS, MRCVS, founder and CEO of CarefreeCredit (pictured right), said: "I first started the company to enable other vets to provide interest-free loans to clients facing large bills for uninsured pets.
"Since then, I’ve been thinking of other ways to help practice staff in our profession and realised a quick and simple low-cost loan facility would be a great way to go beyond helping their clients to helping the staff themselves in their daily lives.
"Now, with just a simple phone call taking just 5 minutes, veterinary staff can easily access the finance they want for whatever purpose they need."
For further information call 0345 313 0177.
Pfizer Animal Health has confirmed that the agreement to acquire multiple product franchises from the Schering-Plough Corporation has been completed - and approved by the European Commission. Pfizer has acquired these assets for approximately euro 116 million in cash.
The agreement covers all European Union countries and the franchises include all major animal health species including cattle, swine, equine and companion animal. Pfizer executives say the agreement leaves them with the most in-depth coverage of therapeutic areas, and the most highly recognised brands, in the industry. Precise details of the agreement are not being released although additional information on the products concerned will be the subject of further announcements in due course.
Pfizer has acquired certain rights to the following products in the European Economic Area:
Albert Bourla, President of Pfizer Animal Health in Europe, said: "This represents a significant expansion of our product portfolio and strengthens our long term commitment not just to veterinary surgeons, but also to farmers and pet owners. Pfizer spends hundreds of millions of dollars on research and development every year, and brings more new products to market than any other company, but when the opportunity arose to add well known, well respected brands to a portfolio that is already extremely strong, we had little hesitation in taking it."
The Office of Fair Trading has concluded that it has no grounds to take action against IDEXX Laboratories Limited following an investigation into alleged abuses of a dominant position in the veterinary diagnostic testing sector.
The OFT opened its investigation in November 2010 after it received a complaint alleging that IDEXX was abusing a dominant position in the market for the supply of in-clinic pet testing equipment in order to foreclose competition.
The conduct assessed by the OFT included alleged practices of:
The full reasoning for the OFT's conclusion, including details of the methodologies used by the OFT to assess potential theories of harm relating to alleged mixed bundling (also known as multi-product rebates) and alleged predatory pricing in systems markets, is available from the OFT's website, here.
The RCVS has announced that voting is now open for the 2016 Council elections.
Ballot papers with candidate details, biographies and manifestos have been posted to all veterinary surgeons this week.
Eight candidates are standing in the RCVS Council election this year, with the six who receive the most votes joining Council at RCVS Day on Friday 15 July 2016 for a four-year term. The candidates are:
Each candidate in both elections has produced a short video in which they answer two questions which they have selected from those submitted to the RCVS in advance by members of the professions. The videos can be viewed at: www.rcvs.org.uk/vetvote16 along with their biographies, manifesto statements and contact details.
Bradley Viner, RCVS President, said: "Last year the candidate videos had over 3,500 views and we hope to increase that this year as it is a very direct and democratic way of finding out more about each candidate and their views. I would urge each member of the profession, whether vets or veterinary nurses, to make a vote for their preferred candidates as they really can make a difference when it comes to the future direction of the College."
All votes must be cast, either online or by post, by 5pm on Friday 29 April 2016. Online votes for RCVS Council candidates can be made at www.ersvotes.com/vetvote16.
Any veterinary surgeon who has not received a ballot paper should contact Ian Holloway, RCVS Communications Manager, on 020 7202 0727 or i.holloway@rcvs.org.uk.
Sue, who is President of the European Society of Dermatology and an RCVS Specialist, says in a video interview that antimicrobial resistance (AMR) is making otitis externa cases difficult to resolve and that vets can help overcome the problem by rethinking their first line prescription choices.
In the video, created in conjunction with Elanco Animal Health (maker of Osurnia), Sue said: "It’s a sad thing to say but if everybody did manage cases of otitis externa appropriately first time, I probably wouldn’t have a job at all."
"Many of the cases I see as a referral clinician are longstanding cases with very severe, multiply-resistant infections. If we get these cases right on the first occasion with appropriate prescription of drugs, and we don’t hurt dogs so we can give ongoing treatment, then we’d never ever see pseudomonas infection again."
Sue believes part of the problem is that veterinary surgeons are incorrectly saving some of their best first-line treatments for difficult cases. This is perpetuating the antimicrobial resistance problem as cases are being inadvertently mismanaged.
She said: "Florfenicol, which is the active antibiotic in Osurnia, has excellent gram positive activity which makes it an ideal first line choice. However, there’s a misconception that florfenicol is a fluoroquinolone - which it isn’t - so vets are incorrectly ‘saving it’ rather than using it on the first occasion."
Sue also highlights that poor compliance, resulting from the patient’s behavioural problems associated with ear phobia, also has a long-term impact:
"We’ve seen many 'well behaved' dogs that have bitten their owners as a result of fear aggression; we’ve had dogs that have pinned their owners against the wall. I would argue very strongly that if you use long-acting products in dogs on the first occasion then you avoid creating that problem and these dogs don’t become difficult to medicate on a long-term basis."
Sue summarised two factors that vets need to consider when deciding on the appropriate treatment: the right active ingredients to target common first-line pathogens; and the method of application. She urged vets to consider using a long-acting product applied within the practice, removing the need for home treatment to reduce stress for both owner and the dog, improve long-term compliance and maximise clinical outcomes.
To hear Sue’s tips on how to treat cases of otitis, watch the video here – www.osurnia.co.uk
Snowflake previously had a squamous cell carcinoma mass on the right lower eyelid, which was completely removed in 2018.
However, her owner noticed an abnormal growth in the left eye, and brought her back to the RVC.
On presentation, Snowflake was bright and in good body condition, weighing 71kg.
Both eyes were open and appeared comfortable and visual.
Ocular reflexes and responses were also present as expected and there was no evidence of recurrence of the squamous cell carcinoma on the lower right eyelid.
Snowflake was, however, diagnosed with mild cataracts in her right eye deemed unlikely to interfere with her vision.
In addition, the mass of her left third eyelid was nonpigmented and displayed a poorly defined mass-like lesion, with an irregular surface on the leading edge, appearing consistent with a squamous cell carcinoma.
The team, led by Dr Maria-Christine Fischer, Lecturer in Ophthalmology, Dr Sara Lawrence-Mills, Senior Clinical Training Fellow in Anaesthesia, and Dr Carolina Palacios Jimenez, Lecturer in Anaesthesia, decided to undertake surgery.
They removed the third eyelid under sedation and applied local anaesthetic blocks and topical tetracaine eye drops.
Cryotherapy was then applied to the wound edge as an adjunctive therapy.
The RVC says that to date, there are few publications detailing anaesthesia in reindeer and so this protocol was a novel approach to maintaining a safe level of sedation in a well-domesticated animal.
The College added that the use of these nerve blocks to facilitate ophthalmic surgery has not been reported before and is in the process of being published.
Snowflake’s third eyelid was submitted for histopathology, which confirmed the diagnosis of squamous cell carcinoma, which the team at the RVC was able to remove completely.
During the process, Snowflake’s daughter was with her so they both remained calm, and she has now made a full recovery and has enjoyed being reunited with her herd.
Maria-Christine said: “Snowflake had a cancerous mass on her third eye lid.
"Surgical removal of the third eyelid in a reindeer has not been reported before.
"We were pleased that we could perform the surgery with Snowflake under a standing sedation and with using local anaesthetics.
"As an ophthalmologist, I am committed to preserving vision so it’s rewarding that we were able to completely excise the tumour and did not have to remove the eyeball. It’s a very good outcome.
"I’m also pleased that Snowflake recovered quickly from the procedure, and we were able to share the protocol of the sedation and the local nerve blocks with other vets via a scientific publication.
"Sharing our knowledge will hopefully be beneficial for future ophthalmic surgeries in reindeer.”
* aka Mr Nick Dean.
Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.
Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.
In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain.
In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.
Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."
For further information on Rycarfa, please contact Dechra on 01939 211200.
*Gfk sales data 1 July 2011
Companion Care Vets has announced it will work in partnership with VetAbroad, an e-learning company that has been established to help vets who qualified outside the UK to develop a successful career within it.
Companion Care is the first veterinary group in the UK to enter into partnership with VetAbroad, with the aim that all new non-UK employees will complete the course.
According to the company, almost 30% of vets registered in the UK are from overseas and statistics show that one in three will leave the register in less than 24 months and 20% in less than 12 months. Statistics also highlight the likelihood of a non-UK vet to be struck off or suspended is six times higher than for a UK vet.
Jane Balmain, Managing Director of Companion Care Vets said: "Whilst we as a company offer as much support as possible to our team members from overseas and support their continued learning , we are delighted to be working in partnership with VetAbroad to utilise their training solutions and further enhance what we offer to team members who come from overseas. All new employees will be required to take the course and we will also be encouraging our current overseas vets to complete it."
The e-course covers social and professional adaptation, compliance with current legislation, teamwork, productivity, client care and communication skills and VetAbroad states that those taking the course will substantially increase their chances of retaining and obtaining a job in the UK.
Vet and founder of VetAbroad Luis Sainz-Pardos said: "The primary aim of our course is to help vets who have qualified overseas to swiftly integrate into the UK system. Vets who have taken the course will be aware of UK legislation and should be able to interact with colleagues, clients and patients to a UK standard. As a result, the problems often associated with employing non-UK vets to work in UK practices are greatly reduced. I am thrilled to be working in partnership with Companion Care Vets, a company that I believe is thriving due to its investment in its most important asset - people."
For further information about VetAbroad please visit www.vetabroad.com
Alstoe, maker of a range of veterinary products including Easeflex, Vetergesic, Dolagis and Nelio, has announced that it has changed its name to Sogeval UK Ltd following its acquisition by Sogeval, the French veterinary drug company, earlier this year.
The company says customers will not notice any change to their dealings with the company, because Sogeval UK Ltd will trade from the same premises near York and with the same staff members.
Niall McFerran, Sogeval Country Manager, UK and ROI said: "The change of name to Sogeval UK Ltd aligns the business to one of the world's fastest growing Animal Health companies. Through Sogeval's research and development programmes, we look forward to exciting improvements in the future."
For any questions relating to the change, practices are invited to contact Niall McFerran on 01347 878606.
Wiley has announced the joint online publication of a special issue of 22 ophthalmology papers from Equine Veterinary Journal, Equine Veterinary Education and Veterinary Ophthalmology.
Clinical equine ophthalmology: The current state of the art brings together papers on some of the most significant advances in equine clinical ophthalmology into a single issue to make them more readily available to a wider audience. The issue contains information of direct relevance to all sectors of the veterinary profession from general practitioners and specialists to researchers, surgeons and students, covering common diseases, surgical procedures and outcomes.
The new publication was devised and compiled by a panel of guest editors comprising Mary Lassaline, member of the Veterinary Ophthalmology Editorial board and Veterinary Ophthalmologist in the Department of Surgical and Radiological Sciences at UC-Davis School of Veterinary Medicine, California, David A. Wilkie, Editor of Veterinary Ophthalmology and Professor at Veterinary Clinical Sciences Comparative Ophthalmology Ohio State University, Tim Mair, Editor of Equine Veterinary Education based at Bell Equine Veterinary Clinic, Kent and Celia M Marr, Editor of Equine Veterinary Journal, based at Rossdales, Newmarket.Mary Lassaline said: "The goal was to provide broad access to the most current information applicable to every stratum of the equine veterinary profession. Subsequently, a salient feature is that many of the papers included are collaborations between veterinary ophthalmologists with a special interest in horses, equine practitioners with a special interest in ophthalmology, private practitioners and those in academia, and academicians from different institutions."
Subjects covered include seven papers on new approaches to the diagnosis and treatment of ulcerative and non-ulcerative keratitis in the horse. There are three articles on novel approaches to corneal surgery and a further three on corneal neoplasia. Six papers provide valuable data regarding long-term outcomes following surgical intervention for Equine Recurrent Uveitis (ERU), glaucoma, and cataracts. Finally, three articles present new information regarding retinal and orbital disease.
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "The key purpose of the EVJ is to disseminate information to help the enhancement of specialist knowledge at every level of the veterinary profession. By collating the most important and up-to-date ophthalmology research into one easy resource the new special issue does exactly that."The ophthalmology special issue is available free online at: http://bit.ly/1bi0RG0
The BSAVA has announced the publication of its latest practical guide: The BSAVA Manual of Canine and Feline Abdominal Surgery.
The new manual covers everything from routine ovariohysterectomy to emergency drainage for acute peritonitis and features two new chapters on laparoscopic instrumentation/surgery and urinary incontinence.
The extensively revised and updated second edition equips veterinary surgeons with practical information, illustrations and images, along with step-by-step operative techniques that provide information on patient positioning and preparation, instrumentation and postoperative management for a variety of procedures.
International expertise includes editors John Williams and Jacqui Niles, as well as contributions from vets around the world.
The BSAVA says that hundreds of veterinary surgeons registered interest in advance after the first edition went out of print last year (2014) and a preview copy was made available at the BSAVA Congress in April.
John Williams said: "The BSAVA exists to promote excellence in small animal practice through education and science, and the BSAVA Manuals are instrumental in fulfilling this aim. As editors of this latest edition, Jacqui and I have had the privilege of being able to work with experts in their respective fields, to produce a practical guide packed full of the latest developments in abdominal surgical techniques that will be useful to the whole veterinary profession."
You can now buy a copy from the BSAVA website: www.bsava.com or by ringing: 01452 726700.
Melvyn was instrumental in shaping the success of the Trap, Neuter, Return, method of controlling feral cat populations. After meeting 60's supermodel Celia Hammond, scientist Dr. Jenny Remfry, and Peter Neville, a research biologist for UFAW, acted on their requests for better and more humane traps and engineered his first trap - the Eziset.
Melvyn went on to develop a dog grasper and a wide range of other handling products widely used in veterinary practice. He then developed the Mikki Muzzle, on the back of which he launched Mikki Pet Products, adding a range of grooming products.
In 1998, Melvyn sold Mikki to focus on his real passion – developing high welfare animal handling equipment and products sold via MDC Exports.
Ian MacFarlaine RVN said: "His impact on the veterinary world is only eclipsed by how much of a contribution he's made to animal charities globally, not just in inventing stuff, but then discounting it readily (through good and bad economic times) and then if that wasn't enough, giving thousands of pounds worth of it away at the ICAWC conference every year.
"If you were privileged enough to know him well, then you'll miss the kindness, the mischievous humour and the occasional bad taste joke. But I can guarantee that a little bit of Melvyn is there in each and every one of your practices in the form of one piece of equipment or other."
The new packaging uses fewer plastic components and a new cardboard box.
Sabrina Jordan, Virbac’s Equine Product Manager said: "The new cardboard component is a substantial step forward making the new packaging more environmentally friendly."
She added: "This new Equimax packaging has a fresh new look and is now available at wholesalers."
Fort Dodge Index (FDI) data for the first six months of 2009 confirm the downward trend in key veterinary practice metrics, including turnover growth, transaction volume and client numbers with a national picture emerging of much slower growth than the same time last year. The one mitigating factor continues to be an increase in the prices charged by practices for their services, which is leading to a small increase in average transaction values.
The FDI (www.fortdodgeindex.co.uk) analyses and benchmarks the performance of practices across the UK. Figures for the first half of 2009 confirm the trend, seen for some time, of static or steadily declining performance in key areas for practices. The national picture of turnover growth and its components for the period January-June 2009 shows that:
Patrick Traill, Corporate Account Manager at Fort Dodge, said: "While some practices are continuing to report busy months and high turnover, it's clear that many are experiencing a rough ride as the recession in the wider economy affects the spending power of pet owners.
"The key challenge is that profits are being eroded at a time when turnover is also being seriously hit. The only impetus for growth so far this year has been the increase in consulting, surgical and drug fees and this alone will not help practices plan for a secure future.
"The latest FDI data confirms a trend which we've been reporting for some time and we urge those who haven't yet taken action to do so without delay. While capturing new clients will always be fundamental to growth, in these times reducing client losses is equally critical and resource may well be better spent on plans that support client retention.
"Practices should also be considering initiatives to increase client visit frequency and support client bonding. Examples could include preventative health schemes and loyalty programmes. Finally, practices could also explore avenues to increase annual transaction value through the promotion of new products and services.
"Joining the FDI is an effective way for practices to benchmark their performance both against others in their locality and across the UK. Full details on the FDI, the benefits it offers to practices and how to join are available on our newly re-designed website. Full copies of the FDI report can also now be downloaded on a quarterly basis."
A copy of the latest FDI report is available for free download at http://www.fortdodgeindex.co.uk/. Further information on how to join the scheme is available from Fort Dodge on 01489 781811.
Her Royal Highness Princess Anne has opened the Royal Veterinary College's new Teaching and Research Centre.
The Centre - at the college's Hawkshead Campus in Potters Bar, Hertfordshire - will provide a home for the RVC's lifestyle research, which includes conditions such as obesity/diabetes, chronic kidney disease and arthritis as well as those with genetic roots.
RVC Principal Professor Stuart Reid said: "The RVC is extremely proud to have welcomed Her Royal Highness to open the new Teaching and Research Centre - a facility where our students are taught within an environment that is all about advanced scientific discovery and first class research. The building houses the engine of academic enquiry and is a wonderful space where our academic community generates new insights into diseases that affect humans and animals.
"The Centre allows us to tie together the various threads we have around the study of illnesses that result from lifestyle in humans and animals, such as those associated with age or genetic disorders. Our College collaborates with the research hub that is the London scientific research community. We are extremely well placed to carry out the work in conjunction with human medical research groups and bring the veterinary perspective to the understanding of disease. The building offers new opportunities, both nationally and internationally".
Funding for the building of the new centre was provided by HEFCE and The Wolfson Foundation.
Photo: Paul West
BCF has announced a number of special deals available on a variety of ultrasound and X-ray products.
With the launch of the new Mindray DP-50 ultrasound scanner, available exclusively from BCF, the company is offering a free trolley and a year's supply of gel.
If you buy a Carestream Vita CR X-ray system and generator from BCF, the company will update your X-ray protection with 3 gowns and 2 thyroid protectors (worth £600, €750) free.
Purchase an Easi-Scan with one battery, and you'll get a second battery and carry bag for free.
Buy an equine DR X-ray system and you'll receive £1,000 (€1,250) to spend on Podoblocks accessories.
Call +44 (0)1506 460 023 or visit www.bcftechnology.com for further information. Offers valid until 31st June.
International Cat Care (formerly the Feline Advisory Bureau) is once again raising the issue of cats accidentally poisoned by dog flea products containing permethrin.
The charity is undertaking a campaign to warn owners of the dangers of using dog flea products on their cats because cats are still dying unnecessarily. While the incidents outlined here occurred in the UK, previous reports have shown that this is the most common cause of poisoning of cats in many countries because products are widely and easily available.
Gary Rutland RVN DipAVN(Surgical), Head Nurse and Cat Advocate at the Cat Friendly Millennium Veterinary Practice in Essex was moved to get in contact with International Cat Care after the death of a nine-week-old kitten treated with a permethrin-containing dog spot-on bought at a local pet store. Understandably, both the owners and the practice staff were greatly distressed. The owner used it on her dog and, because it was cheap, assumed it would 'not be strong' and would be fine to use on the kitten. A video of the kitten on the ICC website (www.icatcare.org/permethrin/cat-deaths) shows the resulting seizures.
The second incident concerned two 7-year-old cats treated accidentally after Donna, their owner, bought a dog spot-on containing permethrin from a local shop without wearing her glasses. Someone had placed a dog treatment among the cat treatments and she picked it up. No advice was given to Donna in the shop. She said that the flea treatments were on the shelves, 'just like selling smarties in a children's candy store'.
Although both products had a warning on the packaging, this was either not seen or not taken seriously enough because such products are so freely available and nobody thinks that a drop of a dog product could kill their cat.
International Cat Care is demanding that dog spot-on flea products containing permethrin should not be available without verbal advice at the point of sale. Currently these products are categorised by the Veterinary Medicines Directorate (VMD) in the UK as AVM-GSL, which means that they can be bought directly off the shop shelf without the need for advice. The charity says they should be recategorised as NFA-VPS so that they can only be purchased if there is someone in the shop who is suitably qualified to speak to and advise the buyer. The shop should advise that they are only for use on dogs, and ask if there are any cats in the home which could come into contact with a recently-treated dog. The owners can then be warned to keep the dog and cat apart, or advised to use a different product. Advice must be given with some other current non-permethrin containing spot-on products sold through pet shops under the NFA-VPS authorisation and many of these products have a much safer profile if used accidentally on cats, than those containing permethrin.
Dr Andy Sparkes, Veterinary Director for International Cat Care, said: 'Many practices see permethrin poisoning in cats several times a year but do not contact the VMD because the product is not a POM or they feel that the Directorate already knows about the problem. We feel strongly that the problem is greatly under-reported. Nothing will be done unless the full extent of the problem is realised by the VMD, so please report each one by going on the website at https://www.vmd.defra.gov.uk/adversereactionreporting/. These cat deaths are totally preventable - you can sign our petition at www.icatcare.org/permethrin/petition to change the categorisation.'
The charity is also asking the pet trade to voluntarily class these dog spot-on products containing permethrin as NFA-VPS and to provide advice to their customers accordingly. Pets at Home is working with International Cat Care and the company will be adding a till prompt so that the product cannot be sold without customers being asked whether they have a cat and given appropriate advice.
Maeve Moorcroft, Head of Pets at Pets at Home which earlier this year launched its Flea Fight Force said: 'We take the risk of permethrin poisoning in cats very seriously. We are introducing prompts at our tills so that customers are asked during the checkout process if they are aware of the risk to cats in the home when purchasing a permethrin based spot-on dog flea treatment, and also advised to wait at least 72 hours after treating the dog before the dog and cat can come into close contact.'
International Cat Care is urging veterinary practices to ensure that if concentrated permethrin-containing spot-on products are prescribed and dispensed for use on dogs, adequate warnings are given, including when owners come in for repeat prescriptions. Asking if there is a cat in the house each time a product is dispensed is critical in case a cat has recently been added to the home.
Information on the veterinary treatment of permethrin poisoning cases can be found on the ICC website at www.icatcare.org/permethrin/vet-info
CM Research has announced the results of a survey conducted this month in which veterinary surgeons named Osurnia as the best new product of 2015.
290 companion animal veterinary surgeons took part in the survey, which is designed to provide veterinary surgeons with their peers’ unbiased judgement on which new veterinary products, services or devices have made the biggest impact on the industry.
The questions were unprompted to ensure that the respondents were not influenced by pre-set survey options. CM Research points to the fact that many of the products that featured in its rankings were launched before 2015, including 2nd and 3rd placed Apoquel and Bravecto, as evidence of this freedom.
The full list of products named more than once in this year's survey was:
Product
Manufacturer
Number of mentions
% of mentions
Osurnia
Elanco
67
23%
Apoquel
Zoetis
58
20%
Bravecto
MSD
29
10%
Semintra
Boehringer Ingelheim (BI)
13
4%
Amodip
Ceva
10
3%
Nexgard Spectra
Merial
8
Broadline
6
2%
UpCard
Vetoquinol
Zodon
5
Metabolic Diet
Hill's
4
1%
Nexgard
SDMA Test
IDEXX
Comfortis
3
Remend
Bayer
Seresto
Yumove
Lintbells
Bovela
BI
2
Comfortan
Dechra
Hill's y/d diet
Nutraquin
Nutravet
Pexion
Prinovox
Virbac
Pronefra
Thiafeline
Animalcare
Veraflox
Vetigel
Suneris
Cardalis